Arrowhead Pharmaceuticals, Inc. (ARWR) stock forecast and price target
Price $47.78 · data as of November 13, 2026
12-month price target
Average target$106.07
Upside / downside+122.0%
Analysts14
ConsensusStrong buy
Low $73.00Average $106.07High $126.00
Gold marker: average target · white marker: today’s price ($47.78)
Analyst ratings
Strong buy 4Buy 10Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends September 30, 2027 | $-5.52 | −52.9% | $266M |
| Next fiscal year ends September 30, 2028 | $-3.26 | +41.0% | $492M |
| Next quarter ends December 31, 2026 | $-1.86 | −945.4% | $36M |
| Quarter after ends March 31, 2027 | $-1.52 | −63.0% | $62M |
Consensus of the analysts covering Arrowhead Pharmaceuticals, updated daily. In the last 30 days 0 estimates were raised and 6 lowered.
Frequently asked questions
What is the Arrowhead Pharmaceuticals stock price target?
The average 12-month target from 14 analysts is $106.07, 122.0% above the current price of $47.78 Targets range from $73.00 to $126.00.
Is Arrowhead Pharmaceuticals a buy according to analysts?
The consensus rating is “Strong buy” (4 strong buy, 10 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Arrowhead Pharmaceuticals expected to earn?
Analysts expect EPS of $-5.52 for the fiscal year ending September 30, 2027 and $-3.26 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.